ESR1 and systemic lupus erythematosus: The identification in SLE patients of serum autoantibodies that react with mERα (anti-ERα Abs) and act as estrogen agonists [15] has made the scenario even more complex, opening a new path for the research in the estrogen-related receptor activity.